Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117125) titled 'An clinical trial of intravenous human immunoglobulin for the treatment of multifocal motor neuropathy' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
multifocal motor neuropathy,MMN
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: NA:6;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305005
Disclaimer: Curated by HT Syndication....